Grant Life Sciences Inc. (OTC BB: GLIF) announced today that it has signed a Memorandum of Understanding (MOU) with Thailand-based i+MED Laboratories Co. Ltd. to distribute i+MED’s point-of-care rapid diagnostic tests via Grant’s established marketing channels in India, Taiwan, Indonesia, Mexico, Middle East and Africa and expand into other countries later.
